| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Departments of 1 Physiology and 2 Medicine and the 3 Banting and Best Diabetes Centre, The Toronto Hospital, University of Toronto, Toronto, Ontario, Canada M5S 1A8
Glucagon-like peptide 2 (GLP-2) has recently been identified as a novel intestinal growth factor. Because experimental diabetes is associated with bowel growth, we examined the relationship between GLP-2 and intestinal growth in rats made diabetic by streptozotocin (STZ) injection and treated with or without insulin for 3 wk. Ileal concentrations of the intestinal proglucagon-derived peptides, i.e., glicentin + oxyntomodulin, and GLPs 1 and 2, were increased by 57 ± 20% above those of controls in untreated STZ diabetes (P < 0.05-0.001). Similar increases in plasma concentrations of glicentin + oxyntomodulin (77 ± 15% above controls, P < 0.01) and GLP-2 (91 ± 32% above controls, P < 0.05) were seen in untreated STZ diabetes. Both wet and dry small intestinal weight increased by 74 ± 20% above controls (P < 0.01) in STZ diabetes, and macromolecular analysis indicated parallel increases in both protein (P < 0.001) and lipid (P < 0.05) content. Villus height (P < 0.001) and crypt depth (P < 0.01) were also increased in untreated diabetic rat intestine. Insulin therapy prevented the changes in plasma GLP-2 and intestinal mass seen in untreated STZ diabetes. Thus STZ diabetes is associated with both increased production of GLP-2 and enhanced bowel weight, thereby suggesting a role for GLP-2 in diabetes-associated bowel growth.
small intestine; adaptation
This article has been cited by other articles:
|
|
 |
|
  D J Drucker Gut adaptation and the glucagon-like peptides Gut, March 1, 2002; 50(3): 428 - 435. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Ljungmann, B. Hartmann, P. Kissmeyer-Nielsen, A. Flyvbjerg, J. J. Holst, and S. Laurberg Time-dependent intestinal adaptation and GLP-2 alterations after small bowel resection in rats Am J Physiol Gastrointest Liver Physiol, September 1, 2001; 281(3): G779 - G785. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Takahara, M. Fujimura, S. Taniguchi, N. Hayashi, T. Nakamura, and M. Fujimiya Changes in serotonin levels and 5-HT receptor activity in duodenum of streptozotocin-diabetic rats Am J Physiol Gastrointest Liver Physiol, September 1, 2001; 281(3): G798 - G808. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J Thulesen, B Hartmann, C Nielsen, J J Holst, and S S Poulsen Diabetic intestinal growth adaptation and glucagon-like peptide 2 in the rat: effects of dietary fibre Gut, November 1, 1999; 45(5): 672 - 678. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. M. Jehle, R. D. Fussgaenger, N. K. O. Angelus, R. J. Jungwirth, B. Saile, and M. P. Lutz Proinsulin stimulates growth of small intestinal crypt-like cells acting via specific receptors Am J Physiol Endocrinol Metab, February 1, 1999; 276(2): E262 - E268. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
